Collaborations (Tables)

12 Months Ended

Dec. 31, 2021

Janssen Biotech, Inc

Collaborative Arrangements and Non-collaborative Arrangement Transactions

Schedule of profit and cost sharing relationship

The following table shows the profit and cost sharing relationship between Janssen and AbbVie:

years ended December 31 (in millions)	2021		2020		2019
United States - Janssen's share of profits (included in cost of products sold)	$	2,018	$	2,012	$	1,803
International - AbbVie's share of profits (included in net revenues)	1,087		1,009		844
Global - AbbVie's share of other costs (included in respective line items)	304		295		321

Genentech, Inc.

Collaborative Arrangements and Non-collaborative Arrangement Transactions

Schedule of profit and cost sharing relationship

The following table shows the profit and cost sharing relationship between Genentech and AbbVie:

years ended December 31 (in millions)	2021		2020		2019
Genentech's share of profits, including royalties (included in cost of products sold)	$	703	$	533	$	320
AbbVie's share of sales and marketing costs from U.S. collaboration (included in SG&A)	40		46		41
AbbVie's share of development costs (included in R&D)	140		129		128